Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Sequencing Paradox of Immunotherapy and Thoracic Radiotherapy.

JAMA oncology·2026
Same author

Automatic Tenure-Clock Extensions as a Safeguard Against Defunding.

Annals of internal medicine·2026
Same author

Performance of Stereotactic Radiotherapy vs Hippocampal-Avoidance Whole Brain Radiation.

JAMA oncology·2026
Same author

Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE Study.

Clinical colorectal cancer·2026
Same author

Jurisdiction firearm prevalence and increasing suicide in United States adolescents and young adults.

Journal of the National Medical Association·2025
Same author

Dosimetric evaluations using cycle-consistent generative adversarial network synthetic CT for MR-guided adaptive radiation therapy.

Frontiers in oncology·2025

Related Experiment Video

Updated: Jun 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Conditional Survival in Rectal Cancer: A SEER Database Analysis.

Samuel J Wang1, Clifton D Fuller, Rachel Emery

  • 1Department of Radiation Medicine and Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR.

Gastrointestinal Cancer Research : GCR
|March 6, 2009
PubMed
Summary

Conditional survival (CS) offers better prognostic insights for rectal cancer patients. The largest CS gains are seen in advanced-stage and younger patients, improving survival predictions post-diagnosis.

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 25, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Oncology
  • Biostatistics
  • Public Health

Background:

  • Cancer survival statistics traditionally rely on time from diagnosis.
  • Conditional survival (CS) provides updated prognostic information for patients who have already survived a specific period.
  • Rectal cancer survival rates can be significantly influenced by factors beyond initial diagnosis.

Purpose of the Study:

  • To analyze conditional survival (CS) rates in a large cohort of rectal cancer patients.
  • To assess how CS varies by disease stage, age, sex, and race.
  • To highlight the improved prognostic value of CS for rectal cancer survivors.

Main Methods:

  • Utilized data from 36,321 rectal cancer patients diagnosed between 1988 and 1998.
  • Employed the Surveillance, Epidemiology, and End Results (SEER 17) database for analysis.
  • Calculated observed 5-year CS rates using the life-table method, stratified by demographic and clinical factors.

Main Results:

  • Conditional survival significantly improves for rectal cancer patients as they survive longer post-diagnosis, especially for advanced stages (e.g., Stage IV increased from 6% to 48%).
  • Patients under 65 had notably better CS than older patients (81% vs. 59% at 5 years post-diagnosis).
  • Men and Black patients generally exhibited slightly lower conditional survival rates compared to women and white patients, respectively.

Conclusions:

  • Conditional survival demonstrates substantial improvement for rectal cancer patients who have already survived initial treatment, particularly those with advanced disease or under 65.
  • CS offers more precise and personalized prognostic information for rectal cancer survivors.
  • These findings underscore the importance of considering conditional survival in managing and counseling rectal cancer patients.